333 related articles for article (PubMed ID: 28719465)
21. UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line.
Warner KA; Oklejas AE; Pearson AT; Zhang Z; Wu W; Divi V; Rodriguez-Ramirez C; Castilho RM; Polverini PJ; Nör JE
Oral Oncol; 2018 Dec; 87():21-28. PubMed ID: 30527239
[TBL] [Abstract][Full Text] [Related]
22. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
[TBL] [Abstract][Full Text] [Related]
23. Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.
Brayer KJ; Frerich CA; Kang H; Ness SA
Cancer Discov; 2016 Feb; 6(2):176-87. PubMed ID: 26631070
[TBL] [Abstract][Full Text] [Related]
24. Ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands.
Bazarsad S; Kim JY; Zhang X; Kim KY; Lee DY; Ryu MH; Kim J
Yonsei Med J; 2018 Aug; 59(6):717-726. PubMed ID: 29978608
[TBL] [Abstract][Full Text] [Related]
25. Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement.
Chen TY; Keeney MG; Chintakuntlawar AV; Knutson DL; Kloft-Nelson S; Greipp PT; Garrity JA; Salomao DR; Garcia JJ
Eye (Lond); 2017 May; 31(5):720-725. PubMed ID: 28085142
[TBL] [Abstract][Full Text] [Related]
26. Small Subset of Adenoid Cystic Carcinoma of the Skin Is Associated With Alterations of the MYBL1 Gene Similar to Their Extracutaneous Counterparts.
Kyrpychova L; Vanecek T; Grossmann P; Martinek P; Steiner P; Hadravsky L; Belousova IE; Shelekhova KV; Svajdler M; Dubinsky P; Michal M; Kazakov DV
Am J Dermatopathol; 2018 Oct; 40(10):721-726. PubMed ID: 29570128
[TBL] [Abstract][Full Text] [Related]
27. MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts.
Togashi Y; Dobashi A; Sakata S; Sato Y; Baba S; Seto A; Mitani H; Kawabata K; Takeuchi K
Mod Pathol; 2018 Jun; 31(6):934-946. PubMed ID: 29410490
[TBL] [Abstract][Full Text] [Related]
28. A subset of prostatic basal cell carcinomas harbor the MYB rearrangement of adenoid cystic carcinoma.
Bishop JA; Yonescu R; Epstein JI; Westra WH
Hum Pathol; 2015 Aug; 46(8):1204-8. PubMed ID: 26089205
[TBL] [Abstract][Full Text] [Related]
29. Development and characterization of xenograft model systems for adenoid cystic carcinoma.
Moskaluk CA; Baras AS; Mancuso SA; Fan H; Davidson RJ; Dirks DC; Golden WL; Frierson HF
Lab Invest; 2011 Oct; 91(10):1480-90. PubMed ID: 21709671
[TBL] [Abstract][Full Text] [Related]
30. Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma.
Persson M; Andrén Y; Moskaluk CA; Frierson HF; Cooke SL; Futreal PA; Kling T; Nelander S; Nordkvist A; Persson F; Stenman G
Genes Chromosomes Cancer; 2012 Aug; 51(8):805-17. PubMed ID: 22505352
[TBL] [Abstract][Full Text] [Related]
31. MYB-NFIB fusion transcript in adenoid cystic carcinoma: Current state of knowledge and future directions.
Wagner VP; Bingle CD; Bingle L
Crit Rev Oncol Hematol; 2022 Aug; 176():103745. PubMed ID: 35738530
[TBL] [Abstract][Full Text] [Related]
32. In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.
Bell D; Bell AH; Bondaruk J; Hanna EY; Weber RS
Cancer; 2016 May; 122(10):1513-22. PubMed ID: 26953815
[TBL] [Abstract][Full Text] [Related]
33. MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma.
Xu LH; Zhao F; Yang WW; Chen CW; Du ZH; Fu M; Ge XY; Li SL
Int J Oncol; 2019 May; 54(5):1579-1590. PubMed ID: 30896785
[TBL] [Abstract][Full Text] [Related]
34. Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance.
Sun J; Luo Y; Tian Z; Gu L; Xia SC; Yu Y
BMC Cancer; 2012 Oct; 12():499. PubMed ID: 23110497
[TBL] [Abstract][Full Text] [Related]
35. High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma.
Vékony H; Raaphorst FM; Otte AP; van Lohuizen M; Leemans CR; van der Waal I; Bloemena E
J Clin Pathol; 2008 Jun; 61(6):744-9. PubMed ID: 18326020
[TBL] [Abstract][Full Text] [Related]
36. t(6;9)(MYB-NFIB) in head and neck adenoid cystic carcinoma: A systematic review with meta-analysis.
de Almeida-Pinto YD; Costa SFDS; de Andrade BAB; Altemani A; Vargas PA; Abreu LG; Fonseca FP
Oral Dis; 2019 Jul; 25(5):1277-1282. PubMed ID: 30269389
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic and prognostic factors in adenoid cystic carcinoma of head and neck minor salivary glands: A clinical analysis of 130 cases.
He S; Li P; Zhong Q; Hou L; Yu Z; Huang Z; Chen X; Fang J; Chen X
Am J Otolaryngol; 2017; 38(2):157-162. PubMed ID: 28041635
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome.
Mitani Y; Roberts DB; Fatani H; Weber RS; Kies MS; Lippman SM; El-Naggar AK
PLoS One; 2013; 8(6):e66778. PubMed ID: 23825564
[TBL] [Abstract][Full Text] [Related]
39. Toll-like receptor 5 and 7 expression in adenoid cystic carcinoma of major salivary glands.
Hirvonen K; Bäck L; Haglund C; Leivo I; Jouhi L; Mäkitie AA; Hagström J
Tumour Biol; 2016 Aug; 37(8):10959-64. PubMed ID: 26888781
[TBL] [Abstract][Full Text] [Related]
40. Adenoid cystic carcinoma: emerging role of translocations and gene fusions.
Wysocki PT; Izumchenko E; Meir J; Ha PK; Sidransky D; Brait M
Oncotarget; 2016 Oct; 7(40):66239-66254. PubMed ID: 27533466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
